US Broker Ratings

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook Highlights Robust Revenue Growth and Analyst Confidence

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical company based in Foster City, California, has been capturing the attention of investors with its innovative approach to treating..

Artivion, Inc. (AORT) Stock Analysis: Navigating a 5.95% Potential Upside in the Medical Device Sector

Artivion, Inc. (AORT), a prominent player in the medical devices industry, is drawing significant interest from investors eager to tap into its promising growth potential. With..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Unpacking a Potential 712% Upside in the Biotech Arena

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning force in the biotechnology sector, is capturing the attention of investors with its ambitious pipeline and the potential for significant..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem with Nearly 49% Upside

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a dynamic player in the biotechnology sector, is capturing the attention of investors with its promising therapeutic developments and substantial..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A Potential 31.89% Upside in Biotechnology

Investors with an eye on the biotechnology sector may find Centessa Pharmaceuticals plc (NASDAQ: CNTA) a compelling opportunity, especially with analysts forecasting a potential upside of..

ImmunityBio, Inc. (IBRX) Stock Analysis: A 296.89% Potential Upside Captures Investor Attention

ImmunityBio, Inc. (NASDAQ: IBRX) is making waves in the biotechnology sector with a remarkable potential upside of nearly 297%, according to current analyst ratings. This San..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 49.75% Potential Upside in Biotech

For investors with a keen interest in the biotechnology sector, Travere Therapeutics, Inc. (NASDAQ: TVTX) presents an intriguing opportunity. This San Diego-based biopharmaceutical company operates in..

Mesoblast Limited (MESO): Investor Outlook Highlights 68.54% Potential Upside

Mesoblast Limited (NASDAQ: MESO), a key player in the biotechnology sector, is currently capturing investor attention with a compelling potential upside of 68.54%, based on its..

Azenta, Inc. (AZTA) Investor Outlook: Navigating the Healthcare Sector with a 17% Upside Potential

Azenta, Inc. (AZTA), a key player in the healthcare sector, focuses on providing innovative sample exploration and management solutions for the life sciences industry. Based in..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a Potential 116.94% Upside in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of the biotechnology sector, focusing on the discovery and development of therapeutics for neurodegenerative and lysosomal storage..

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 39.66% Potential Upside for Savvy Investors

QuidelOrtho Corporation (NASDAQ: QDEL), a significant player in the healthcare sector, particularly within the medical devices industry, presents an intriguing opportunity for investors seeking exposure to..

PROCEPT BioRobotics (PRCT) Stock Analysis: Exploring a 79.78% Potential Upside in the Medical Device Sector

PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a key player in the medical device sector, is capturing the attention of investors with its innovative solutions in urology. Headquartered..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Unveiling the Potential Upside Amidst a Robust Buy Rating Consensus

For investors looking to tap into the dynamic world of biotechnology, Kymera Therapeutics, Inc. (NASDAQ: KYMR) presents an intriguing opportunity. With a market capitalization of $4.18..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Exploring a 24.87% Upside Potential

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a leader in the behavioral healthcare sector, presents a compelling opportunity for investors seeking exposure to the healthcare industry. With..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 31.89% Potential Upside in the Healthcare Sector

Progyny, Inc. (PGNY), a prominent player in the healthcare sector, stands out with its innovative fertility and family-building benefits solutions. Headquartered in New York, the company..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Unpacking a 25% Potential Upside in Healthcare Innovation

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands at an intriguing juncture for investors seeking opportunities in the dynamic healthcare sector. With a market capitalization of $1.4 billion,..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Biotech Gem with 114.78% Potential Upside

For investors with a keen eye on the biotechnology sector, Celldex Therapeutics, Inc. (NASDAQ: CLDX) presents a compelling opportunity. With a market capitalization of $1.74 billion,..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Promising Upside of 94.13% Amidst Biotechnology Innovation

For investors seeking opportunities in the biotechnology sector, Beam Therapeutics Inc. (NASDAQ: BEAM) presents a compelling prospect. With a significant market capitalization of $2.42 billion and..

AtriCure, Inc. (ATRC) Stock Analysis: Unpacking a 43.39% Potential Upside in the Healthcare Sector

AtriCure, Inc. (NASDAQ: ATRC) is capturing the attention of investors with its promising potential for significant upside, amid a 17.10% revenue growth and a robust Buy..

Certara, Inc. (CERT) Investor Outlook: Unpacking the 17.41% Potential Upside in the Healthcare Sector

Certara, Inc. (NASDAQ: CERT), a pivotal player in the healthcare sector, operates at the intersection of technology and biosimulation. With a market capitalization of $1.96 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds